HomeNDC LookupRxCUI directory › RxCUI 1298874

Mecamylamine hydrochloride 2.5 MG Oral Tablet — RxCUI 1298874

RxNorm drug concept · Semantic clinical drug
RxCUI 1298874 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1298874
Official nameMecamylamine hydrochloride 2.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmecamylamine HCl 2.5 MG Oral Tablet
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Mecamylamine hydrochloride 2.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Mecamylamine hydrochloride 2.5 MG Oral Tablet RxCUI 1298874

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Mecamylamine 6673
    • Mecamylamine hydrochloride 91240
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vecamyl 1373003
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mecamylamine Oral Tablet 372728
    • Mecamylamine hydrochloride Oral Tablet 2646068
    • Mecamylamine Oral Product 1158650
    • Mecamylamine Pill 1158651
    • Mecamylamine hydrochloride Oral Product 2659400
    • Mecamylamine hydrochloride Pill 2660076
    • Mecamylamine Oral Tablet [Vecamyl] 1373005
    • Mecamylamine hydrochloride Oral Tablet [Vecamyl] 2657064
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Mecamylamine hydrochloride 2.5 MG SCDC · 1298873
  • Mecamylamine Oral Tablet SCDF · 372728
  • Mecamylamine hydrochloride Oral Tablet SCDFP · 2646068
  • Mecamylamine Oral Product SCDG · 1158650
  • Mecamylamine Pill SCDG · 1158651
  • Mecamylamine hydrochloride Oral Product SCDGP · 2659400
  • Mecamylamine hydrochloride Pill SCDGP · 2660076

Brand-Name Concepts

  • Mecamylamine hydrochloride 2.5 MG Oral Tablet [Vecamyl] SBD · 1373008
  • Mecamylamine hydrochloride 2.5 MG [Vecamyl] SBDC · 1373004
  • Mecamylamine Oral Tablet [Vecamyl] SBDF · 1373005
  • Mecamylamine hydrochloride Oral Tablet [Vecamyl] SBDFP · 2657064
  • Vecamyl Oral Product SBDG · 1373006
  • Vecamyl Pill SBDG · 1373007
  • Vecamyl BN · 1373003

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1298874 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69413-0558-40 100 TABLET in 1 BOTTLE (69413-558-40) Vecamyl Vyera Pharmaceuticals, LLC 2013-03-19
83649-0558-01 100 TABLET in 1 BOTTLE (83649-558-01) Vecamyl TILDE Sciences LLC 2025-02-20
Observed labelers: TILDE Sciences LLC (1) · Vyera Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.